搜索
Pacific Biosciences of California Inc
PACB添加自选
1.350USD
+0.050+3.85%
收盘 09-14 16:00（美东）
418.04M总市值
亏损市盈率 TTM
Pacific Biosciences of California Inc (PACB) 营收表现
更新时间: 2026年6月30日去年，Pacific Biosciences of California Inc表现最佳的业务板块Consumable revenue实现营收81.94M美元。North America的营收贡献最高，去年达到72.80M美元。 最近一个季度，截至2026-06-30，Pacific Biosciences of California Inc表现最佳的业务板块Consumable revenue实现营收20.11M美元。North America的营收贡献最高，达到17.62M美元。
业务
营业收入
占比
年报
年报
单季报
Consumable revenue
Instrument revenue
Service And Other
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
Consumable revenue
81.94M(51.21%)
70.37M(45.69%)
63.42M(31.63%)
59.98M(46.75%)
52.18M(39.98%)
31.14M(39.47%)
32.62M(35.88%)
37.86M(48.16%)
Instrument revenue
53.82M(33.64%)
65.78M(42.71%)
120.45M(60.07%)
48.72M(37.97%)
61.32M(46.99%)
34.28M(43.45%)
45.13M(49.65%)
28.49M(36.24%)
Service And Other
24.25M(15.15%)
17.86M(11.60%)
16.65M(8.30%)
19.61M(15.28%)
17.01M(13.03%)
13.47M(17.07%)
13.15M(14.47%)
12.27M(15.61%)
地区
营业收入
占比
年报
年报
单季报
North America
Europe (including the Middle East and Africa)
Asia Pacific
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
North America
72.80M(45.50%)
78.71M(51.11%)
105.41M(52.57%)
69.56M(54.22%)
64.52M(49.44%)
37.28M(47.25%)
44.68M(49.16%)
35.60M(45.28%)
40.60M(43.42%)
50.80M(56.01%)
68.80M(74.14%)
34.80M(57.43%)
13.60M(48.23%)
11.40M(43.85%)
27.60M(81.42%)
Europe (including the Middle East and Africa)
44.05M(27.53%)
34.59M(22.46%)
40.66M(20.28%)
22.60M(17.61%)
30.27M(23.19%)
19.07M(24.17%)
19.60M(21.56%)
13.96M(17.75%)
13.20M(14.12%)
20.00M(22.05%)
9.00M(9.70%)
10.10M(16.67%)
9.20M(32.62%)
6.60M(25.38%)
5.10M(15.04%)
Asia Pacific
43.16M(26.97%)
40.71M(26.43%)
54.45M(27.16%)
36.15M(28.17%)
35.72M(27.37%)
22.55M(28.58%)
26.61M(29.28%)
29.07M(36.97%)
39.70M(42.46%)
19.90M(21.94%)
15.00M(16.16%)
15.70M(25.91%)
5.40M(19.15%)
8.00M(30.77%)
1.20M(3.54%)